Kim Chang Sing Pang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kim Chang Sing Pang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Lawrence Faden
Harvard Medical School, Boston, Massachusetts
3 shared publications Douglas M. Hildrew
Department of Otolaryngology-Head and Neck Surgery Yale University School of Medicine New Haven Connecticut USA
1 shared publication- Douglas M. Hildrew
Yale School of Medicine, New Haven, Connecticut, USA
1 shared publication - Louise Collins
Department of Otolaryngology–Head and Neck Surgery, Massachusetts Eye and Ear, Boston, MA 02114, USA
1 shared publication - Sowmya R. Rao
Boston University School of Public Health Department of Global Health Boston, MA , USA
1 shared publication - Taha Mur
Department of Otolaryngology, Boston Medical Center and Boston University School of Medicine, Boston, MA, United States of America
1 shared publication
Latest Publications
- Open Access
Human Papillomavirus in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Human papillomavirus (HPV) drives tumorigenesis in a subset of oropharyngeal squamous cell carcinomas (OPSCC) and is increasing in prevalence across the world. Mounting evidence suggests HPV is also involved in a subset of sinonasal squamous cell carcinomas (SNSCC), yet small sample sizes and variability of HPV detection techniques in existing literature hinder definitive conclusions. A systematic review was performed by searching literature through March 29th 2020 using PubMed, Embase, and Web of Science Core Collection databases. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed by two authors independently. A meta-analysis was performed using the random-effects model. Sixty studies (n = 1449) were eligible for statistical analysis estimating an overall HPV prevalence of 25.5% (95% CI 20.7–31.0). When stratified by HPV detection method, prevalence with multiple substrate testing (20.5%, 95% CI 14.5–28.2) was lower than with single substrate testing (31.7%, 95% CI 23.6–41.1), highest in high-exposure anatomic subsites (nasal cavity and ethmoids) (37.6%, 95% CI 26.5–50.2) vs. low-exposure (15.1%, 95% CI 7.3–28.6) and highest in high HPV+ OPSCC prevalence geographic regions (North America) (30.9%, 95% CI 21.9–41.5) vs. low (Africa) (13.1, 95% CI 6.5–24.5)). While small sample sizes and variability in data cloud firm conclusions, here, we provide a new reference point prevalence for HPV in SNSCC along with orthogonal data supporting a causative role for virally driven tumorigenesis, including that HPV is more commonly found in sinonasal subsites with increased exposure to refluxed oropharyngeal secretions and in geographic regions where HPV+ OPSCC is more prevalent.
Open AccessHuman Papillomavirus in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Human papillomavirus (HPV) drives tumorigenesis in a subset of oropharyngeal squamous cell carcinomas (OPSCC) and is increasing in prevalence across the world. Mounting evidence suggests HPV is also involved in a subset of sinonasal squamous cell carcinomas (SNSCC), yet small sample sizes and variability of HPV detection techniques in existing literature hinder definitive conclusions. A systematic review was performed by searching literature through March 29th 2020 using PubMed, Embase, and Web of Science Core Collection databases. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed by two authors independently. A meta-analysis was performed using the random-effects model. Sixty studies (n = 1449) were eligible for statistical analysis estimating an overall HPV prevalence of 25.5% (95% CI 20.7–31.0). When stratified by HPV detection method, prevalence with multiple substrate testing (20.5%, 95% CI 14.5–28.2) was lower than with single substrate testing (31.7%, 95% CI 23.6–41.1), highest in high-exposure anatomic subsites (nasal cavity and ethmoids) (37.6%, 95% CI 26.5–50.2) vs. low-exposure (15.1%, 95% CI 7.3–28.6) and highest in high HPV+ OPSCC prevalence geographic regions (North America) (30.9%, 95% CI 21.9–41.5) vs. low (Africa) (13.1, 95% CI 6.5–24.5)). While small sample sizes and variability in data cloud firm conclusions, here, we provide a new reference point prevalence for HPV in SNSCC along with orthogonal data supporting a causative role for virally driven tumorigenesis, including that HPV is more commonly found in sinonasal subsites with increased exposure to refluxed oropharyngeal secretions and in geographic regions where HPV+ OPSCC is more prevalent.
- Open Access
- 11 September 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (5) , 839-845
Otolaryngology in the time of COVID: An overview of common open‐source telemedicine platforms
- 11 September 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (5) , 839-845
Open AccessOtolaryngology in the time of COVID: An overview of common open‐source telemedicine platforms
- Open Access
- 1 June 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (3) , 584-585
The age of telemedicine is upon us
- 1 June 2020
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 5 (3) , 584-585
Open AccessThe age of telemedicine is upon us